Cancer cells often exhibit enhanced glutamine uptake and metabolism. This is facilitated by the overexpression of glutamine transporters such as ASCT2 and LAT1. Once inside the cell, glutamine can be converted into glutamate through the action of glutaminase (GLS). Glutamate can then enter the tricarboxylic acid (TCA) cycle, providing intermediates for energy production and biosynthetic processes.
